The information in the following tables relates only to registered
shareholders and does not include holders of unregistered shares.
Also, the information provided in the tables below cannot be
assumed to be representative of the entire Novartis investor base
since nominees and JPMorgan Chase Bank, as ADS depositary, are
registered as shareholders for a large number of beneficial owners.
As of December 31, 2012, Novartis had approximately 161 000 registered shareholders.